Oncology Institute (DFPH) Shares Outstanding (2019 - 2026)

Oncology Institute (DFPH) has 8 years of Shares Outstanding data on file, last reported at $101.7 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding rose 12.18% year-over-year to $101.7 million; the trailing twelve-month figure through Mar 2026 stood at $101.7 million (up 12.18% YoY), and the FY2025 full-year result was $98.9 million, up 27.61% from the prior year.
• Shares Outstanding for Q1 2026 stood at $101.7 million, up from $98.9 million in the prior quarter.
• Across five years, Shares Outstanding topped out at $100.6 million in Q4 2025 and bottomed at $72.0 million in Q2 2022.
• The 5-year median for Shares Outstanding is $76.0 million (2024), against an average of $81.4 million.
• The widest annual swing landed in 2022, when Shares Outstanding slumped 99.75%; it then jumped 44636.09% in 2023.
• A 5-year view of Shares Outstanding shows it stood at $73.3 million in 2022, then climbed by 3.57% to $75.9 million in 2023, then increased by 2.1% to $77.5 million in 2024, then increased by 27.61% to $98.9 million in 2025, then climbed by 2.88% to $101.7 million in 2026.
• The last three Shares Outstanding figures came in at $101.7 million (Q1 2026), $98.9 million (Q4 2025), and $97.6 million (Q3 2025), per Business Quant data.

Peer Comparison